Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status
10.18632/oncotarget.28047
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Published: |
Impact Journals LLC
2022
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/233145 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| id |
sg-nus-scholar.10635-233145 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2331452024-04-17T08:40:06Z Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status Marijon, Hélène Gery, Sigal Chang, Hua Landesman, Yosef Shacham, Sharon Lee, Dhong Hyun de Gramont, Aimery Koeffler, Harold Phillip MEDICINE BRCA1 Olaparib Selinexor Triple negative breast cancer XPO1 10.18632/oncotarget.28047 Oncotarget 12 18 1749-1762 2022-10-13T07:34:41Z 2022-10-13T07:34:41Z 2021-08-31 Article Marijon, Hélène, Gery, Sigal, Chang, Hua, Landesman, Yosef, Shacham, Sharon, Lee, Dhong Hyun, de Gramont, Aimery, Koeffler, Harold Phillip (2021-08-31). Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status. Oncotarget 12 (18) : 1749-1762. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.28047 1949-2553 https://scholarbank.nus.edu.sg/handle/10635/233145 Attribution 4.0 International https://creativecommons.org/licenses/by/4.0/ Impact Journals LLC Scopus OA2021 |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| topic |
BRCA1 Olaparib Selinexor Triple negative breast cancer XPO1 |
| spellingShingle |
BRCA1 Olaparib Selinexor Triple negative breast cancer XPO1 Marijon, Hélène Gery, Sigal Chang, Hua Landesman, Yosef Shacham, Sharon Lee, Dhong Hyun de Gramont, Aimery Koeffler, Harold Phillip Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status |
| description |
10.18632/oncotarget.28047 |
| author2 |
MEDICINE |
| author_facet |
MEDICINE Marijon, Hélène Gery, Sigal Chang, Hua Landesman, Yosef Shacham, Sharon Lee, Dhong Hyun de Gramont, Aimery Koeffler, Harold Phillip |
| format |
Article |
| author |
Marijon, Hélène Gery, Sigal Chang, Hua Landesman, Yosef Shacham, Sharon Lee, Dhong Hyun de Gramont, Aimery Koeffler, Harold Phillip |
| author_sort |
Marijon, Hélène |
| title |
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status |
| title_short |
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status |
| title_full |
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status |
| title_fullStr |
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status |
| title_full_unstemmed |
Selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of BRCA1 mutation status |
| title_sort |
selinexor, a selective inhibitor of nuclear export, enhances the anti-tumor activity of olaparib in triple negative breast cancer regardless of brca1 mutation status |
| publisher |
Impact Journals LLC |
| publishDate |
2022 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/233145 |
| _version_ |
1800915656333328384 |